Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsOvercoming resistance to complement-dependent cytotoxicity (CDC) and achieving efficient lysis of low-density antigens remain persistent hurdles in antibody therapy. Creative Biolabs addresses these challenges through specialized Fc engineering that enhances hexamerization and optimizes C1q recruitment. Our Complement Activation Service delivers tailored solutions across diverse antibody formats, amplifying CDC potency against refractory targets. By applying advanced molecular design, we equip clients with next-generation candidates that combine potent complement engagement with excellent developability profiles.
Fc engineering plays a pivotal role in unlocking the full therapeutic potential of antibodies by precisely modulating immune effector functions. Through our advanced Fc engineering platform, we enable customized antibody design, strategically introducing mutations and structural modifications to tailor immunological activity. These engineered antibodies are specifically optimized to enhance complement activation, driving robust C1q engagement and hexamerization for potent CDC-mediated tumor cell elimination.
Fig.1 Fc-mediated complement enhancement.
Creative Biolabs specializes in the tailored design of Fc-engineered antibodies precisely calibrated to initiate classical complement cascade activation. We cater to investigators seeking customized solutions, fine-tuning Fc architecture to reconcile potent cytolytic activity with optimal safety parameters. From innovative bispecific constructs to advanced monoclonal candidates for hematologic oncology, our molecular expertise enables the systematic construction of high-efficacy therapeutics with built-in complement functionality.
Our advanced Fc engineering platform integrates six precision-engineered strategies to dramatically potentiate complement-mediated antibody activity. Through targeted structural remodeling of the Fc domain, we optimize antibody architecture to facilitate superior C1q recruitment and stabilize hexamer formation on the cell surface.
Required Starting Materials: To begin a tailored collaboration, we request the variable domain sequences (Fab or scFv), detailed antigen characteristics, including surface expression levels, and a defined effector function objective.
Key Steps:
Final Deliverables: We deliver the purified, lead-optimized Fc variant, the sequence-verified expression construct, and a complete dataset comprising CDC dose-response profiles and structural integrity assessments.
We specialize in customized Fc engineering that precisely programs complement activation to match your therapeutic goals. Through advanced hexamerization enhancement and C1q affinity modulation, we transform standard antibodies into potent CDC effectors. Our platform optionally integrates FcγR silencing to prevent off-target toxicity, while proprietary sweeping and recycling technologies extend half-life, delivering durable, high-efficacy candidates tailored for complex tumor microenvironments.
"Creative Biolabs' Fc engineering transformed our therapeutic candidate, delivering superior complement activation that far exceeded standard IgG1 performance." Dr. J***n H.
"We required a bispecific combining silenced effector functions with enhanced CDC. Their Fc-engineered solution met all preclinical safety benchmarks on first evaluation." Sarah L***z.
"Their hexamerization expertise is exceptional. The Fc-engineered variants demonstrated outstanding stability and a substantially expanded therapeutic window in our CLL models." Prof. M***o R.
Creative Biolabs delivers state-of-the-art Fc Engineering-based Complement Activation Services, designed to expedite therapeutic development and enhance effector function. Our team provides scientifically validated approaches and strategic guidance to help you achieve precise objectives.
To explore collaborative opportunities or request a customized project plan, please contact our dedicated specialists.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
